← k3vl4r
Log inGet started →

IRD Price Forecast

AI-generated price forecast for IRD across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

As of July 2026: K3vl4r's AI model currently reads IRD as 3/4 bearish across its horizons (1 of 4 timeframes pointing up), with a last price of 3.60. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status

Last price

3.60

AI outlook

3/4 bearish

Timeframes up

1 / 4

Share𝕏 Post✈ Telegram

IRD forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour~3 weeks out▲ Up+44.43%—
4-hour~3 months out▼ Down-30.06%—
Daily~6 months out▼ Down-29.56%0%
Weekly~2 years out▼ Down-5.90%—

Latest IRD news

From the market-news feed the forecasts are read against.

  • Opus Genetics Expects To Announce Three-month Topline Data From Cohort 1 Of Phase 1/2 Trial Of OPGx-BEST1 For Best Vitelliform Macular Dystrophy Or Autosomal-recessive Bestrophinopath, During The Second Week Of September 2026 · Benzinga · Jul 9
  • BTIG Reiterates Buy on Opus Genetics, Maintains $12 Price Target · Benzinga · Jul 6
  • Opus Genetics Aligns With FDA In A Type B Rare Disease Meeting On Design Of Its Registrational Phase 3 Clinical Trial Evaluating OPGX-lCA5 For Early-Onset Severe Inherited Retinal Dystrophy · Benzinga · Jul 6
  • RBC Capital Bullish On Opus Genetics (IRD) Amid Limited Competition And De-Risked Setup · Insider Monkey · Jul 5
  • Opus Genetics Set To Join Russell 3000, 2000, Microcap Indexes, Effective June 29 · Benzinga · Jun 26

🔒

See the full IRD forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

IRD forecast — frequently asked

Will IRD go up?

K3vl4r's AI model currently reads IRD as 3/4 bearish — 1 of 4 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the IRD price prediction for 2026?

K3vl4r's model projects IRD toward $4.02 over the next ~3 weeks, a +0.4% move from $4.01. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could IRD reach?

Over its longest horizon (~~2 years), the model's projected target for IRD is $3.74 (-0.1% vs $3.74). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

AKTXCRSPPENZYMELIVNEHCRNTXUPCAMRXJANXALXOLNTHNRIXCORT

Will IRD reach…?

Will IRD reach $5.00?Will IRD reach $10.00?Will IRD reach $20.00?Will IRD reach $25.00?

Or see the full IRD price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare IRD

IRD vs AKTXIRD vs CRSPIRD vs PENIRD vs ZYMEIRD vs LIVNIRD vs EHC

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

k3vl4rTop PicksTrack recordChart indicatorsToday's outlookBiggest moversMarket heatmapForecasts by sectorAI reportsCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)Twitch — live forecastingDiscord community

Join the community on Discord and catch live forecasting on Twitch. Create a free account →

Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Status.